المعلومات عن الأدوية مقدَّمة من: IBM Micromedex
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of Rylaze™ in children younger than 1 month of age. Safety and efficacy have not been established.
Appropriate studies have not been performed on the relationship of age to the effects of Rylaze™ in the geriatric population. Safety and efficacy have not been established.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
Bleeding problems caused by L-asparaginase treatment, history of or
Blood clotting problems caused by L-asparaginase treatment, history of or
Pancreatitis caused by L-asparaginase treatment, history of—Should not be given to patients with these conditions.
Bleeding problems or
Blood clotting problems or
Liver disease or
Pancreatitis (swelling of the pancreas)—Use with caution. May make these conditions worse.